Welcome to our dedicated page for Ainos SEC filings (Ticker: AIMD), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Ainos, Inc. filings document operating results, material agreements, governance matters, and the securities structure of a Nasdaq-listed company with AIMD common stock and AIMDW warrants. Form 8-K reports cover annual and quarterly financial results, AI Nose commercialization updates, distribution rights for AINOS AI Nose products and services, and amendments to product-development and patent-use arrangements.
The company’s proxy materials disclose director elections, shareholder voting matters, compensation information, and governance procedures. Its filings also describe relationships involving Taiwan Carbon Nano Technology Corporation and Ainos KY, including control and voting-power matters relevant to the company’s corporate governance and development agreements.
Taiwan Carbon Nano Technology Corp, a more than 10% owner of Ainos, Inc., reported selling 46,000 shares of Ainos common stock on January 28, 2026 at an average price of $2.1697 per share for general operating purposes.
After this transaction, the reporting shareholder directly owned 989,925 Ainos common shares.
ScentAI Inc., a wholly owned subsidiary of Ainos, Inc., filed a Schedule 13D reporting beneficial ownership of 1,160,000 shares of Ainos common stock, representing 16.50% of the outstanding class. These shares have no voting power for so long as they are held by the wholly owned subsidiary.
ScentAI acquired the 1,160,000 Ainos shares on December 30, 2025 in exchange for 116,000,000 shares of ScentAI common stock. The filing states the stake was acquired for investment and general corporate purposes and notes that ScentAI currently has no specific plans for corporate actions involving Ainos, though it may review and change its intentions over time.
Taiwan Carbon Nano Technology Corp, a 10% owner of Ainos, Inc., reported small open-market sales of Ainos common stock. On January 8, 2026, it sold 850 shares at $1.8048 per share, leaving 1,036,356 shares beneficially owned. On January 9, 2026, it sold an additional 431 shares at $1.86 per share, after which it held 1,035,925 shares directly.
According to the footnote, the reporting person sold these shares of common stock for general operating purposes.
Ainos, Inc. reported that on December 30, 2025 it entered into a distribution agreement with Trusval Technology Co. Ltd. covering its AINOS AI Nose and related products and services. The agreement runs for three years and provides Trusval with one-year exclusive distribution rights for Products sold to certain clients, after which exclusivity may change according to the contract terms. This arrangement is intended to govern how Ainos’ AI Nose offerings reach designated customers through Trusval as a distributor.
Ainos, Inc. (AIMD) reported that one of its directors acquired additional equity in the company. On November 25, 2025, the director received 50,000 shares of common stock as special stock awards at a price of $2.10 per share, increasing the director’s holdings to 91,280 shares held directly. The filing shows related derivative entries for 50,000 RSUs that were acquired and then converted into the same number of common shares on the same date.
The company’s stockholders had previously approved these special stock awards on November 7, 2025, indicating that this equity grant was part of an authorized compensation arrangement. This transaction aligns the director’s interests more closely with the performance of Ainos, Inc. through a larger direct ownership stake.
Ainos, Inc. (AIMD) reported an insider equity award for its CEO, President and Chairman, Chun-Hsien Tsai. On November 25, 2025, he acquired 80,000 shares of common stock at a reported price of $2.10 per share, classified as an acquisition of non-derivative securities. Following this transaction, he beneficially owned 410,372 shares of Ainos common stock directly.
The filing also shows related derivative activity, where 80,000 restricted stock units (RSUs) were converted into the same number of common shares and the RSU balance went to zero. The company notes these 80,000 shares were granted and vested as special stock awards on November 25, 2025, after having been approved by Ainos stockholders on November 7, 2025.
Ainos, Inc. (AIMD) director received a special stock award that resulted in the acquisition of 80,000 shares of common stock on November 25, 2025 at a price of $2.10 per share. These shares were granted and fully vested as special stock awards that had been approved by Ainos stockholders on November 7, 2025. Following this transaction, the reporting person now beneficially owns 365,707 shares of Ainos common stock directly.
Ainos, Inc. (AIMD) reported an insider equity award to one of its directors. On November 25, 2025, the reporting person received a grant of 50,000 shares of common stock as special stock awards, which were granted and vested on the same date at a reported price of $2.10 per share. These awards had been approved by Ainos stockholders on November 7, 2025.
Following this transaction, the director beneficially owns 101,546 shares of Ainos common stock in direct ownership. The filing also shows related movements in derivative securities (RSUs) that correspond to the 50,000 underlying common shares, with the RSU position moving to zero after conversion into common stock.
Ainos, Inc. (AIMD) reported an insider equity transaction by a director. On 11/25/2025, the reporting person received 50,000 shares of common stock as special stock awards at a reported price of $2.10 per share, increasing their directly held stake to 90,880 shares after the transaction. These 50,000 shares were granted and vested as part of special stock awards that had been approved by Ainos stockholders on 11/7/2025. The filing also shows related movements in restricted stock units and their conversion into common stock.
Ainos, Inc. (AIMD) reported an insider equity transaction by a director. On November 25, 2025, the director received 50,000 shares of common stock as special stock awards, which were granted and vested on that date. The awards were previously approved by Ainos stockholders on November 7, 2025.
The filing shows the 50,000 shares were acquired at a price of $2.10 per share, increasing the director’s directly held stake to 90,880 shares of Ainos common stock following the transaction. The Form 4 also reflects related movements in restricted stock units (RSUs) that converted into the same number of common shares.